COVID-19 Related Recurrent Pericarditis: A Case Report
Case Report
DOI:
https://doi.org/10.5281/zenodo.8011444Keywords:
COVID-19, pericarditis, Colchicine, IbuprofenAbstract
Coronavirus Disease (2019). (Covid-19), caused by the Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2) virus, is a pandemic infection widely seen worldwide and has a very high mortality rate. This infection, which often has upper and lower respiratory tract symptoms, may present with atypical presentations with different clinical pictures in the recent period. Respiratory and cardiac system findings are at the forefront of Covid-19, a multisystem involvement infection. Cardiac involvement may present as myocarditis, pericarditis, rhythm disturbances, heart failure, and acute coronary syndrome. Although mostof the cases diagnosed with Covid-related pericarditis have been reported as pericarditis accompanying respiratory system findings, it is known that there arepatients diagnosed as isolated pericarditis cases. There is no different diagnosis and treatment protocol in pericarditis cases due to SARS-CoV-2 compared to other viral pericarditis cases in terms of diagnosis and treatment.
Our case; Following the diagnosis of Covid-19 infection, he was examined with complaints of increasing back pain and numbness spreading to the left arm, and pericarditis was detected on echocardiography, and treatment planning was made. It was learned that the patient was diagnosed with Covid infection two years ago and with pericarditis due to the examinations performed due to similar symptoms following the PCR positivity and was treated by admission to the cardiology service. This case report aims to draw attention to the fact that Covid-19 infection may occur in different forms, raise awareness regarding early recognition of the complications, and do the necessary treatment planning.
References
Dashraath P, Wong J.L, Lim M.X, et al. Coronavirus Disease 2019(COVID 19) Pandemic and Pregnancy. American Journal Of Obstetrics and Gynecology. 2020;222: 521-531.
Xu Z, Shi L, Wang Y, et al. Pathological Findings of COVID-19 Associated with Acute Respiratory Distress Syndrome. Lancet Respir.Med. 2020;8:420-422.
Clerkin K, Fried JA, Raikhelkar J, et al. COVID-19 and Cardiovascular Disease.Circulation,2020;141:1648-1655. Doi:10.1161/CIRCULATIONAHA.120.046941 DRUG
Kochi A, Tagliari A, Battista G, et al. Cardiac and arrhythmic complications in patients with COVİD-19. Journal of Cardiovascular Electrophysiology. 2020;31:1003-1008.
Imazio M, Brucato A, Lazaros G, et al. Anti-inflammatory therapies for pericardial diseases in the COVID-19 pandemic: safety and potentiality. J Cardiovasc Med (Hagerstown). 2020;21(9):625-629. doi:10.2459/JCM.0000000000001059
Chen YT. Acute Pericarditis due to COVID-19 infection:An underdiagnosed disease? Med Clin(Eng Ed). 2020;155(1):44-46. Doi:10.1016/j.medcle.2020.06.001
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Acta Medica Ruha
This work is licensed under a Creative Commons Attribution 4.0 International License.